PORTLAND, Ore.--(BUSINESS WIRE)--Bioject Medical Technologies Inc., (OTCBB: BJCT), a leading developer of needle-free injection therapy systems, announced today that the Company will report its financial results for the third quarter ended September 30, 2010 on Wednesday, November 10, 2010, after the close of the financial markets. Management will conduct a conference call on Thursday, November 11, 2010 at 10:00 a.m. Eastern Standard Time to review the results for the quarter. Ralph Makar, President and CEO; Dr. Rick Stout, Executive Vice President and Chief Medical Officer; and Chris Farrell, Vice President of Finance, will be hosting the call.
